RANK ligand
- 1 January 2007
- journal article
- review article
- Published by Elsevier BV in The International Journal of Biochemistry & Cell Biology
- Vol. 39 (6), 1077-1081
- https://doi.org/10.1016/j.biocel.2006.11.008
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Regulation of cancer cell migration and bone metastasis by RANKLNature, 2006
- A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.Clinical Cancer Research, 2006
- Mechanisms of Disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasisNature Clinical Practice Oncology, 2006
- RANKing Intracellular Signaling in OsteoclastsIUBMB Life, 2005
- A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal WomenJournal of Bone and Mineral Research, 2004
- TNF-related Activation-induced Cytokine (TRANCE) Induces Angiogenesis through the Activation of Src and Phospholipase C (PLC) in Human Endothelial CellsJournal of Biological Chemistry, 2002
- The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland DevelopmentCell, 2000
- Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysisNature Genetics, 2000
- Osteoprotegerin and Osteoprotegerin Ligand Mediate the Local Regulation of Bone ResorptionThe Endocrinologist, 2000
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997